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. A member of the D 2 receptor family, the D 3 site is of particular interest because its mRNA is expressed preferentially in brain regions such as the nucleus accumbens, olfactory tubercle, and islands of Calleja (Bouthenet et al. 1991; Sokoloff et al. 1990 ). These brain regions are terminal fields of the mesolimbic dopamine projection that is hypothesized to be involved in producing psychotic symptoms in schizophrenia (Stevens 1973) . Furthermore, unlike mRNA for the D 2 receptor, relatively little D 3 mRNA is expressed in the caudate/ putamen (Bouthenet et al. 1991; Sokoloff et al. 1990 ). This suggests that the D 3 site may be a target for novel antipsychotic drugs that might be free of extrapyramidal effects. It has also been suggested that the D 3 receptor may play a role in the reinforcing properties of cocaine (Caine and Koob 1993) and might thus represent a potential target in the treatment of drug abuse.
Since the cloning of the D 3 receptor, several radioligands thought to be selective for this site have been synthesized including [ 3 H]PD 128907 (R-( ϩ )-trans -3,4,4a, 10b-tetrahydro-4-propyl-2 H ,5 H -[1] benzopyrano [3,4-b] -N EUROPSYCHOPHARMACOLOGY 1998 -VOL . 18 , NO . 4 1,4-oxazin-9-ol]) and [ 3 H]7-OH-DPAT (7-hydroxy-diphenylaminotetralin) (Lévesque et al. 1992) . However, there is some controversy over the selectivity of [ 3 H]7-OH-DPAT for the D 3 receptors over the D 2 (Gonzales and Sibley 1995) . Interaction of the ligand with the sigma site has also been reported . Although confusion over the selectivity of [ 3 H]7-OH-DPAT may be due to the use of different assay protocols, the conflicting reports have limited the utility of this ligand as a tool for the study of D 3 sites in brain. On the other hand, PD 128907 produced behavioral and neurochemical effects in brain suggestive of activity at the D 3 site (Pugsley et al. 1995 ). Likewise, [ 3 H]PD 128907 exhibited significant selectivity in transfected cell lines . However, the utility of this ligand in rat brain has not yet been demonstrated.
Because comprehensive study of a novel receptor system in brain requires the ability to selectively visualize the receptor protein, as well as receptor mRNA, the utility of [ 
MATERIALS AND METHODS

[
H]PD 128907 Binding Assays
The [ 3 H]PD 128907 binding assays were performed according to a modification of the methods of . Discrete brain regions were isolated by freehand dissection on ice from the brains of adult male Sprague-Dawley rats (Harlan Bioproducts, Indianapolis, IN). Brain tissue was homogenized with a PRO250 Homogenizer (setting 4 of 6) for 10 s in 20 volumes of assay buffer (50 mmol/L Tris, 1 mmol/L EDTA; pH 7.4). The crude homogenate was centrifuged twice at 48,000 ϫ g for 15 min, resuspending the pellet in 20 volumes of assay buffer each time. The final pellet from membrane preparation was resuspended in buffer to yield a final concentration of 10 mg original wet weight (o.w.w.)/ ml. Binding assays were performed in duplicate in disposable polystyrene tubes. The final assay volume was 0.5 ml. For binding site saturation studies, 8-10 concentrations of ( ϩ )- [N-propyl-2,3-3 mol/L quinpirole. Preliminary experiments indicated the optimal incubation time at 23 Њ C to be 3 h. The reaction was terminated by rapid filtration through Whatman GF/B filters pretreated with 0.5% polyethyleneimine using a Brandel cell harvester. Filters were washed 3 times with 3 ml ice-cold buffer (50 mmol/L Tris; pH 7.4 at 23 Њ C), and placed in scintillation vials. After the addition of Beckman Ready Protein ϩ scintillation cocktail, vials were shaken, allowed to equilibrate for 2 h, and radioactivity quantitated using a Beckman 6500 scintillation counter. Protein concentrations were determined using the BCA method (Pierce, Rockford, IL). Specific binding of [ 
Receptor Autoradiography with [
H]PD 128907
Adult male Sprague-Dawley (200-300 g; Charles River Laboratories, Wilmington, DE) were killed by decapitation, brains rapidly removed, frozen in isopentane, and stored at Ϫ 70 Њ C until sectioning. Sagittal and coronal brain sections (20 m) were cut on a cryostat, thawmounted onto chrome-alum/gelatin-coated slides and stored at Ϫ 70 Њ C until use.
[ 3 H]PD 128907 autoradiography was performed according to a modification of methods previously described . Optimal assay conditions were determined in preliminary wash-out and association experiments. Slide-mounted brain sections were brought to room temperature and allowed to dry thoroughly. Duplicate sections from the same animal were used for each data point. Slides were incubated with ‫ف‬ 0.7 nmol/L [ Autoradiographic images were digitized and quantified using the Macintosh-based video densitometry program NIH "Image" version 1.4. Best-fit curves of optical density generated by the [ 3 H]methylmethacrylate autoradiographic standards resulted when a Rodbard plot was used to describe the relationship between optical density and radioactivity. Brain regions were identified according to the atlas of Paxinos and Watson (1986) . Autoradiograms of coronal sections were sampled bilaterally. Measurements represent average pixel optical density by volume analysis. Results, expressed as fmol/mg tissue equivalent were not corrected for differential quenching by white and gray matter. Digitized images of autoradiograms from Image were used to generate the figures presented in this article. (Sokoloff et al. 1990; Lévesque et al. 1992; Levant and De Souza 1993; Akunne et al. 1995) (Table  2) . Dopamine agonists exhibited the following rank order of potency in competition with [ (Table 2) .
RESULTS
Radioligand-Binding Studies
Because previous studies have suggested an interaction of [ ](ϩ)-7-OH-DPAT binding assays were performed using ventral striatum and nonspecific binding was defined using 10 mol/L quinpirole. Data were analyzed using the nonlinear, least-squares curve fitting program LIGAND and represent the mean Ϯ SEM of three to four independent determinations. Data from all competition studies were consistent with the interaction of each ligand with a single binding site. H](ϩ)-7-OH-DPAT were observed in the caudate/putamen, hypothalamus, and substantia nigra/ventral tegmental area. Moderately low to low densities of sites were detected in frontal cortex, amygdala, hippocampus, and dorsal vermis. Overall, the regional distributions of sites labeled by these radioligands was highly correlated (r 2 ϭ 0.900).
The regional distribution of [ Figure 3 . These data are quantified in Figure 4 . Overall, comparable substrate specificity of [ 
. Acb ϭ nucleus accumbens, lob X ϭ cerebellar lobule X. Quantified data from these autoradiograms is shown in Figure 4 . .0ف‬ nmol/L and ‫2.0ف‬ nmol/L, respectively. Nonspecific binding was defined by 10 mol/L quinpirole. Data shown represent the mean Ϯ SEM of three independent determinations. Ventral striatum ϭ nucleus accumbens and olfactory tubercle. VTA ϭ ventral tegmental area.
a Data represent the mean to two independent determinations performed with identical results as reported in Levant et al. 1992 . 
DISCUSSION
Because of the potential therapeutic importance of the dopamine D 3 site (Sokoloff et al. 1990; Caine and Koob 1993) , considerable effort has been directed toward understanding its neurobiology. To this end, several radioligands purported to be D 3 selective have been identified including [ gands (Landwehrmeyer et al. 1992; Parsons et al. 1993; Booze and Wallace 1995) . Taken together, the present data suggest the interaction of these radioligands with a common binding site with the characteristics of the D 3 dopamine receptor.
Thus, in our hands, both [ Levant 1996) , indicated no binding above that attributable to the low density of putative D 3 sites present in that tissue. Thus, the affinity of this radioligand for the D 2 receptor is sufficiently low to preclude determination by filtration assay (i.e., K D Ͼ 100 nmol/L) (Bennett and Yamamura 1985) . As such, it is concluded that the D 2 /D 3 receptor selectivity of this radioligand is significantly greater than 300-fold and that labeling of D 2 receptors is negligible under the in vitro assay conditions used in this study. In contrast, similar saturation studies with [ 3 H](ϩ)-7-OH-DPAT revealed binding to a site in caudate/putamen of appropriate density for the D 2 receptor (Levant 1995; Levant et al. 1992 (Bouthenet et al. 1991 ), but relatively little putative D 3 binding. These discrepancies may be due to the transport of receptors to brain regions remote from cell bodies or the differential regulation of transcription and translation in different brain areas. This issue must be resolved by further study.
In summary, the present data demonstrate the binding of [
